Ken Grauer, MD
AUGUST 8, 2024
I was sent the ECG shown in Figure-1 — told only that that this middle-aged woman noted chest tightness and nausea an hour earlier. QUESTIONS: How would YOU interpret the ECG in Figure-1 ? — IF told that this patient arrested shortly after ECG #1 — Does this change your interpretation? Figure-1: The initial ECG in today's case. ( To improve visualization — I've digitized the original EC G using PMcardio ).
Science Daily - Heart Disease
AUGUST 8, 2024
Significant improvements in aerobic fitness were noted after 12 weeks of high-intensity interval training sessions compared to traditional, moderate exercise sessions, according to a new study.
HCPLive
AUGUST 8, 2024
Atopic dermatitis increases stress, depression, anxiety, and suicidal ideation, affecting patients' mental health, a recent study found.
American College of Cardiology
AUGUST 8, 2024
What are the outcomes in patients with chronic heart failure and reduced ejection fraction (HFrEF) as determined by their optimal medical therapy (OMT) score?
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
AUGUST 8, 2024
Treatment with GLP-1 RAs led to improvements in weight loss, liver function tests, and liver fat in patients with diabetes and MASLD, with hepatic improvements independent of weight loss.
American College of Cardiology
AUGUST 8, 2024
A newly released ACC Expert Consensus Decision Pathway (ECDP) focused on the clinical assessment, management and trajectory of patients hospitalized with heart failure (HF) includes revisions to the 2019 version of the document and harmonizes guidance in response to the ACC/AHA Heart Failure Guideline released in 2022.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
American College of Cardiology
AUGUST 8, 2024
What are the patient characteristics, population rates, and 30-day outcomes of pulmonary vein isolation (PVI) in a nationwide sample of US adults aged >65 years?
HCPLive
AUGUST 8, 2024
In this analysis, investigators highlighted the perceptions of individuals with HS and atopic dermatitis and assessed higher rates of stigmatization.
American College of Cardiology
AUGUST 8, 2024
The following are key points to remember from the 2024 update to the 2020 American College of Cardiology/American Heart Association (ACC/AHA) clinical performance and quality measures for adults with heart failure (HF).
HCPLive
AUGUST 8, 2024
Medical experts engage in a discussion surrounding the treatment and management of patients diagnosed with psoriasis and psoriatic arthritis.
Cardiometabolic Health Congress
AUGUST 8, 2024
Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.
HCPLive
AUGUST 8, 2024
In this interview, Chovatiya spoke with the editorial team about the global prevalence findings on patients with seborrheic dermatitis and their implications.
American College of Cardiology
AUGUST 8, 2024
Three new performance measures and six new quality measures are included as part of updated "Clinical Performance and Quality Measures for Adults With Heart Failure" released by the ACC and the American Heart Association (AHA) in collaboration with the Heart Failure Society of America (HFSA) on Aug. 8.
HCPLive
AUGUST 8, 2024
Results showed particular heavy metals increased the risk of arthritis.
Cardiomatics
AUGUST 8, 2024
With more than 30,000 participants, the ESC Congress is by far the most important gathering for the cardiology community in Europe (and beyond). Actually, I do not recommend having any serious cardiac events between August 30th and September 2nd, as everyone will be in London at that time. Cardiomatics has been a part of the Digital Health Area at ESC since the very first edition in Barcelona in 2017.
HCPLive
AUGUST 8, 2024
Study finds 70% of atopic dermatitis patients using dupilumab continued for up to 5 years, but 23.8% discontinued primarily due to adverse events or ineffectiveness.
Frontiers in Cardiovascular Medicine
AUGUST 8, 2024
We provide an overview about the current landscape of transcatheter tricuspid valve interventions (TTVI) and summarize recent findings from trials including TRILUMINATE, TRILUMINATE Pivotal, bRIGHT, TRICLASP, TRISCEND, TRISCEND II, TRICUS, and Cardioband TR EFS. These studies have demonstrated the safety and efficacy of TTVI. Yet, they have failed to show a prognostic benefit over conservative treatment.
HCPLive
AUGUST 8, 2024
Nipocalimab led to a substantially higher percentage of live births at 32 weeks’ gestation or later without intrauterine transfusions than the historical benchmark.
Frontiers in Cardiovascular Medicine
AUGUST 8, 2024
PurposeTo explore molecular mechanisms affecting nutritional risk and neurodevelopment in children with congenital heart disease (CHD) by combining transcriptome and metabolome analysis.MethodsA total of 26 blood and serum samples from 3 groups of children with CHD low nutritional risk combined with normal neurodevelopment (group A), low nutritional risk combined with neurodevelopmental disorders (group B) and high nutritional risk combined with normal neurodevelopment (group C) were analyzed by
HCPLive
AUGUST 8, 2024
Harman Deol, MD begins this series presenting an overview of treatment resistant depression (TRD), highlighting its prevalence along with its impact on patients and the healthcare system.
Frontiers in Cardiovascular Medicine
AUGUST 8, 2024
BackgroundAbnormal substrate on invasive electroanatomic mapping (EAM) correlates with areas of myocardial thinning and fibrofatty replacement in Arrhythmogenic Cardiomyopathy (ACM). However, EAM parameters are absent from all sets of diagnostic criteria for ACM.Case summaryA 41-year-old female with no significant family history was referred for evaluation of frequent premature ventricular complexes (PVCs).
HCPLive
AUGUST 8, 2024
William Sauve, MD shares the growing landscape of treatments for treatment resistant depression (TRD) and their mechanism of action, such as brain stimulation through electroconvulsive therapy or medication such as esketamine.
Frontiers in Cardiovascular Medicine
AUGUST 8, 2024
Out-of-hospital cardiac arrest (OHCA) mostly occurs in crowded public places outside hospitals, such as public sports facilities, airports, railway stations, subway stations, and shopping malls. The emergency department of Liaocheng People's Hospital in Shandong Province admitted one patient with OHCA in August 2021, who suddenly suffered a loss of consciousness and cardiac arrest during exercise after dinner.
HCPLive
AUGUST 8, 2024
Robert Zalewski-Zaragoza, MD expands on the option of esketamine for treatment resistant depression, highlighting the unique mechanism of action and application.
Med Page Today
AUGUST 8, 2024
(MedPage Today) -- Continuous rhythm monitoring after cardiac surgery held clues to help identify people prone to late postoperative atrial fibrillation (POAF) and any associated adverse events. In the RACE V prospective cohort study, over half.
HCPLive
AUGUST 8, 2024
Geoffrey Grammer, MD closes this series highlighting the administration options of esketamine, its safety profile, and the importance of monitoring patients using this treatment.
Becker's Hospital Review - Cardiology
AUGUST 8, 2024
Buffalo, N.Y. based-Catholic Health has started construction on a $13 million cardiac catheterization lab renovation at Mercy Hospital of Buffalo, according to an Aug. 7 report by NBC affiliate WGRZ.
HCPLive
AUGUST 8, 2024
Levels of obesity indicators, including body mass index and waist circumference, were notably higher in patients with gout compared to those without gout.
Cassling
AUGUST 8, 2024
The Investing In You Educational Summit is right around the corner. The full agenda has been unveiled, the state-of-the-art imaging systems you can experience firsthand are all set, and we at Cassling are ready to welcome you to Omaha to see what the future holds for the imaging field. As we get closer to the event on August 26 and 27, we’ve fielded questions from attendees and put together this helpful guide to understanding every aspect of the event.
HCPLive
AUGUST 8, 2024
A panel of medical experts discuss how clinical guidelines currently define clinical remission, as well as the clinical and economic benefits associated with clinical remission.
DAIC
AUGUST 8, 2024
tim.hodson Thu, 08/08/2024 - 10:19 Radiation from X-rays is an occupational hazard for many medical specialists, including cardiologists, vascular and orthopedic surgeons, urologists, some radiologists and gastroenterologists. Especially during the first trimester of pregnancy, radiation exposure for these providers can pose a threat to the fetus. To determine radiation risks to pregnant medical trainees, UCSF researchers conducted a study to determine how well radiation safety measures were en
HCPLive
AUGUST 8, 2024
A panel of medical experts introduce themselves before diving into a discussion about remission achievement in rheumatoid arthritis.
HCPLive
AUGUST 8, 2024
A total of 82.3% of patients in the biosimilars group and 90.9% in the reference drug group achieved an ACR20 response.
The American Journal of Cardiology
AUGUST 8, 2024
Publication date: Available online 7 August 2024 Source: The American Journal of Cardiology Author(s): Johanna A. van der Zande, Karishma P. Ramlakhan, Katja Prokselj, Edison Muñoz-Ortiz, Amalia Baroutidou, Magdalena Lipczynska, Edit Nagy, Tobias Rutz, Arie Franx, Roger Hall, Mark R. Johnson, Jolien W.
HCPLive
AUGUST 8, 2024
Positive topline results from the phase 3 VALIANT study show promise for pegcetacoplan in patients with C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis.
Expert insights. Personalized for you.
126 
Let's personalize your content